{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:55:27Z","timestamp":1791244527677,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Chinese medicine science and technology project funded projects of Zhejiang Province","award":["20162097009594"],"award-info":[{"award-number":["20162097009594"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s12272-019-01186-1","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T14:34:52Z","timestamp":1569335692000},"page":"1012-1020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Schisandrin A ameliorates MPTP-induced Parkinson\u2019s disease in a mouse model via regulation of brain autophagy"],"prefix":"10.1007","volume":"42","author":[{"given":"Yinghao","family":"Zhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"1186_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.amjms.2017.05.002","volume":"354","author":"D Aksoy","year":"2017","unstructured":"Aksoy D, Solmaz V, Cavusoglu T, Meral A, Ates U, Erbas O (2017) Neuroprotective effects of exenatide in a Rotenone-Induced rat model of Parkinson\u2019s disease. Am J Med Sci 354:319\u2013324","journal-title":"Am J Med Sci"},{"key":"1186_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/nn.3489","volume":"16","author":"VS Burchell","year":"2013","unstructured":"Burchell VS, Nelson DE, Sanchez-Martinez A, Delgado-Camprubi M, Ivatt RM, Pogson JH, Randle SJ, Wray S, Lewis PA, Houlden H, Abramov AY, Hardy J, Wood NW, Whitworth AJ, Laman H, Plun-Favreau H (2013) The Parkinson\u2019s disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy. Nat Neurosci 16:1257\u20131265","journal-title":"Nat Neurosci"},{"key":"1186_CR3","doi-asserted-by":"crossref","first-page":"42274","DOI":"10.18632\/oncotarget.9786","volume":"7","author":"M Cheng","year":"2016","unstructured":"Cheng M, Liu L, Lao Y, Liao W, Liao M, Luo X, Wu J, Xie W, Zhang Y, Xu N (2016) MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis. Oncotarget 7:42274\u201342287","journal-title":"Oncotarget"},{"key":"1186_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mcn.2012.07.008","volume":"55","author":"RL De Vries","year":"2013","unstructured":"De Vries RL, Przedborski S (2013) Mitophagy and Parkinson\u2019s disease: be eaten to stay healthy. Mol Cell Neurosci 55:37","journal-title":"Mol Cell Neurosci"},{"key":"1186_CR5","first-page":"721721","volume":"2012","author":"H Di","year":"2012","unstructured":"Di H, Cao Y, He R, Na H, Liu Z, Miao L, Yin J (2012) Schizandrin, an antioxidant Lignan from Schisandra chinensis, ameliorates A\u03b21-42-induced memory impairment in mice. Oxid Med Cell Longev 2012:721721","journal-title":"Oxid Med Cell Longev"},{"key":"1186_CR6","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1038\/emboj.2012.170","volume":"31","author":"N Exner","year":"2012","unstructured":"Exner N, Lutz AK, Haass C, Winklhofer KF (2012) Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences. EMBO J 31:3038\u20133062","journal-title":"EMBO J"},{"key":"1186_CR8","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1055\/s-0032-1320689","volume":"78","author":"D Hu","year":"2012","unstructured":"Hu D, Li C, Han N, Miao L, Wang D, Liu Z, Wang H, Yin J (2012) Deoxyschizandrin isolated from the fruits of Schisandra chinensis ameliorates A\u03b21-42-induced memory impairment in mice. Planta Med 78:1332","journal-title":"Planta Med"},{"key":"1186_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pathophys.2017.02.001","volume":"24","author":"B Kaur","year":"2017","unstructured":"Kaur B, Prakash A (2017) Ceftriaxone attenuates glutamate-mediated neuro-inflammation and restores BDNF in MPTP model of Parkinson\u2019s disease in rats. Pathophysiology 24:71\u201379","journal-title":"Pathophysiology"},{"key":"1186_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/jnr.20089","volume":"76","author":"KA Koo","year":"2004","unstructured":"Koo KA (2004) Dibenzocyclooctadiene lignans from Schisandra chinensis protect primary cultures of rat cortical cells from glutamate-induced toxicity. J Neurosci Res 76:397\u2013405","journal-title":"J Neurosci Res"},{"key":"1186_CR11","first-page":"264","volume":"41","author":"DH Kwon","year":"2018","unstructured":"Kwon DH, Cha HJ, Choi EO, Leem SH, Kim GY, Moon SK, Chang YC, Yun SJ, Hwang HJ, Kim BW (2018) Schisandrin A suppresses lipopolysaccharide-induced inflammation and oxidative stress in RAW 264.7 macrophages by suppressing the NF-\u00ce\u00baB, MAPKs and PI3\u00a0K\/Akt pathways and activating Nrf2\/HO-1 signaling. Int J Mol Med 41:264\u2013274","journal-title":"Int J Mol Med"},{"key":"1186_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.physbeh.2009.04.021","volume":"98","author":"DW Luchtman","year":"2009","unstructured":"Luchtman DW, Shao D, Song C (2009) Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson\u2019s disease. Physiol Behav 98:130","journal-title":"Physiol Behav"},{"key":"1186_CR13","first-page":"329","volume":"27","author":"XQ Qin","year":"2011","unstructured":"Qin XQ, Liang YG, Gao HZ, Qu HY, Dong RH, Wu XW, Li HY, Liu ZY (2011) Reversing mechanism of schizandrin A on multi-drug resistance of K562\/ADR, HL60\/ADR, MCF-7\/ADR cell lines. Chin Pharmacol Bull 27:329\u2013334","journal-title":"Chin Pharmacol Bull"},{"key":"1186_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/mds.870090202","volume":"9","author":"AHV Schapira","year":"1994","unstructured":"Schapira AHV (1994) Evidence for mitochondrial dysfunction in Parkinson\u2019s disease\u2014a critical appraisal. Mov Disord Off J Mov Disord Soc 9:125\u2013138","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1186_CR7","doi-asserted-by":"publisher","first-page":"e0149991","DOI":"10.1371\/journal.pone.0149991","volume":"11","author":"F Song","year":"2016","unstructured":"Song F, Zeng K, Liao L, Yu Q, Tu P, Wang X (2016) Schizandrin A inhibits microglia-mediated neuroninflammation through inhibiting TRAF6-NF-\u03baB and Jak2-Stat3 signaling pathways. PLoS ONE 11:e0149991","journal-title":"PLoS ONE"},{"key":"1186_CR15","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.biopha.2017.10.145","volume":"97","author":"K Sowndhararajan","year":"2017","unstructured":"Sowndhararajan K, Deepa P, Kim M, Park SJ, Kim S (2017) An overview of neuroprotective and cognitive enhancement properties of lignans from Schisandra chinensis. Biomed Pharmacother 97:958\u2013968","journal-title":"Biomed Pharmacother"},{"key":"1186_CR16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1172\/JCI95795","volume":"128","author":"T Steinkellner","year":"2018","unstructured":"Steinkellner T, Zell V, Farino ZJ, Sonders MS, Villeneuve M, Freyberg RJ, Przedborski S, Lu W, Freyberg Z, Hnasko TS (2018) Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons. J Clin Invest 128:774\u2013788","journal-title":"J Clin Invest"},{"key":"1186_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/10717544.2016.1225854","volume":"24","author":"X Su","year":"2017","unstructured":"Su X, Gao C, Shi F, Feng X, Liu L, Qu D, Wang C (2017) A microemulsion co-loaded with Schizandrin A-docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance. Drug Deliv 24:10","journal-title":"Drug Deliv"},{"key":"1186_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/antiox8070198","volume":"8","author":"YL Tiong","year":"2019","unstructured":"Tiong YL, Ng KY, Koh RY, Ponnudurai G, Chye SM (2019) Melatonin prevents oxidative stress-induced mitochondrial dysfunction and apoptosis in high glucose-treated schwann cells via upregulation of Bcl2, NF-kappaB, mTOR, Wnt signalling pathways. Antioxidants (Basel) 8:198","journal-title":"Antioxidants (Basel)"},{"key":"1186_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13105-014-0342-3","volume":"70","author":"CP Wang","year":"2014","unstructured":"Wang CP, Li GC, Shi YW, Zhang XC, Li JL, Wang ZW, Ding F, Liang XM (2014) Neuroprotective effect of schizandrin A on oxygen and glucose deprivation\/reperfusion-induced cell injury in primary culture of rat cortical neurons. J Physiol Biochem 70:735\u2013747","journal-title":"J Physiol Biochem"},{"key":"1186_CR20","doi-asserted-by":"publisher","first-page":"e0132499","DOI":"10.1371\/journal.pone.0132499","volume":"10","author":"W Wu","year":"2015","unstructured":"Wu W, Xu H, Wang Z, Mao Y, Yuan L, Luo W, Cui Z, Cui T, Wang XL, Shen YH (2015) PINK1-Parkin-mediated mitophagy protects mitochondrial integrity and prevents metabolic stress-induced endothelial injury. PLoS ONE 10:e0132499","journal-title":"PLoS ONE"},{"key":"1186_CR21","first-page":"169","volume":"30","author":"Y Zhou","year":"1999","unstructured":"Zhou Y, Xie JX (1999) Parkinson\u2019s disease and oxidative stress. Sheng li ke xue jin zhan [Progress in physiology] 30:169","journal-title":"Sheng li ke xue jin zhan [Progress in physiology]"},{"key":"1186_CR22","first-page":"199","volume":"11","author":"F Zhou","year":"2019","unstructured":"Zhou F, Wang M, Ju J, Wang Y, Liu Z, Zhao X, Yan Y, Yan S, Luo X, Fang Y (2019) Schizandrin A protects against cerebral ischemia-reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK\/Nrf2 pathway regulation. Am J Transl Res 11:199\u2013209","journal-title":"Am J Transl Res"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-019-01186-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-019-01186-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-019-01186-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T23:25:11Z","timestamp":1600817111000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-019-01186-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,24]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1186"],"URL":"https:\/\/doi.org\/10.1007\/s12272-019-01186-1","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,24]]},"assertion":[{"value":"17 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}